Phillip G. Kasirye
Kampala, C, Uganda
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Ten Years of Hydroxyurea for Ugandan Children with Sickle Cell Anemia.
Journal: The New England journal of medicine
Published: May 27, 2026
School absenteeism among children and adolescents aged 6-19 years with sickle cell disease in Uganda: A comparative cross-sectional study.
Journal: PloS one
Published: November 30, 2025
Sickle Cell Lung Disease in a 9-year-Old Presenting with Wheezing: Investigating Causal Relationships, Asthma or Acute Chest Syndrome.
Journal: International medical case reports journal
Published: October 04, 2025
Indications for hospitalisation and predictors of 30-day re-admission of patients with sickle cell disease in Uganda: a retrospective study.
Journal: BMJ open
Published: August 08, 2025
Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls.
Journal: British journal of haematology
Published: April 28, 2025
Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks.
Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025
Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks.
Journal: Pediatric blood & cancer
Published: January 11, 2025
Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross-Sectional Study.
Journal: Pediatric blood & cancer
Published: August 10, 2024
Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study.
Journal: medRxiv : the preprint server for health sciences
Published: July 23, 2024
Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study.
Journal: Frontiers in stroke
Published: June 21, 2024
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.
Journal: Contemporary clinical trials communications
Published: April 24, 2024
Last Updated: 09/26/2026